Δ7-22GeXIVA

General Information


DCTPep ID  DCTPep06242

Peptide Name   Δ7-22GeXIVA

Sequence  RYCRSPYDRRRRYCRR

Sequence Length  16

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

ACP Cancer targeted peptides α9α10nAChR inhibitor



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  α9α10nAChR

Affinity  Not available

Mechanism  Specifically block the α9α10nAChR



Structure Information


PDB ID  Not available

Predicted Structure  Not available

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  Cys3<--->Cys14

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C93H152N40O23S2

Absent amino acids  AEFGHIKLMNQTVW

Theoretical pI  11.24

Acidic residues  1

Basic residues  8

Polar residues  6

Molecular weight (Average)  2262.6

Molecular weight (Monoisotopic)  2261.14

Common amino acids  R

Net charge  7

Instability index (II)  208.16

Aliphatic index  0.00

Grand average of hydropathicity (GRAVY)  -2.550

Half Life 
  1 hours (mammalian reticulocytes, in vitro).
  2 min (yeast, in vivo).
  2 min (Escherichia coli, in vivo).

Extinction coefficients 
  Ext. coefficient 4595
  Abs 0.1% (=1 g/l) 2.031, assuming all pairs of Cys residues form cystines
  Ext. coefficient 4470
  Abs 0.1% (=1 g/l) 1.976, assuming all Cys residues are reduced

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID CN112010972A

Patent Title  Novel alpha O-conotoxin peptide GeXIVA new mutant as well as pharmaceutical composition and application thereof

Other Iinformation  Not available

Other Published ID  Not available




DCTPep is developed by Dr.Zheng's team.